Left Atrial Appendage
Left atrial appendage closure safe, effective first-line option for AF ablation patients
CHICAGO — In the OPTION trial, left atrial appendage closure resulted in similar thromboembolic protection but superior bleeding outcomes compared with oral anticoagulation among patients who underwent ablation for atrial fibrillation.
Less stroke severity, mortality after LAA closure vs. DOAC prophylaxis
In adults with atrial fibrillation who developed ischemic stroke, those treated with left atrial appendage closure had better outcomes than those receiving direct oral anticoagulant prophylaxis, data from a registry analysis show.
LAA exclusion system for use in AF during cardiac surgery cleared, launched in US
Medtronic announced the U.S. launch of its left atrial appendage exclusion system for use during cardiac surgery in patients with preoperative atrial fibrillation.
SWISS-APERO at 1 year: LAA closure outcomes similar for Amulet, Watchman devices
SAN FRANCISCO — One-year data from the SWISS-APERO study show similar clinical outcomes and rates of patent left atrial appendages for patients undergoing LAA closure with either the Amulet or Watchman FLX devices, a speaker reported.
Concomitant left atrial appendage occlusion, TAVR an option for some with AF: WATCH-TAVR
SAN FRANCISCO — Left atrial appendage occlusion at the time of transcatheter aortic valve replacement provides a noninferior treatment option to TAVR plus medical therapy in patients with severe aortic stenosis and atrial fibrillation.
Next-generation LAA closure device for patients with nonvalvular AF gains FDA approval
Boston Scientific announced it received FDA approval for its next-generation left atrial appendage closure device indicated to reduce risk for stroke in certain patients with nonvalvular atrial fibrillation.
Abbott recall of LAAO catheters designated class I
Abbott announced a recall of its cardiac catheter used in procedures for left atrial appendage occlusion due to risk for air embolism, potentially causing stroke or death.
OCEAN-LAAC
Assessing initial experiences in Japan and age-related clinical outcomes in patients with nonvalvular atrial fibrillation undergoing percutaneous left atrial appendage closure.
SCAI, HRS release joint consensus statement on transcatheter LAA closure for AF
The Society for Cardiovascular Angiography and Interventions and the Heart Rhythm Society released an updated expert consensus statement on transcatheter left atrial appendage closure for atrial fibrillation.
Event rates low at 1 year in real-world data from next-generation LAA closure device
A next-generation left atrial appendage closure device was associated with low rates of poor outcomes and high rates of complete seal at 1 year, researchers reported at Cardiovascular Research Technologies.